*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 18.03 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 122,730 | ||||
| Total Hospitalizations with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 590 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter in DRG | 8.19 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 11.0 | ||||
| Readmission Rate at DRG | 21.31 | ||||
| Readmission Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 24.08 | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 19.18 | ||||
| Total Medicare payments at DRG | $1,397,885,220 | ||||
| Total Medicare payments with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $9,898,669 | ||||
| Total Medicare payment per Day at DRG | $1,497 | ||||
| Total Medicare payment per Day with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $1,525 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,390 | ||||
| Total Medicare payment per Hospitalization with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $16,777 | ||||
| Total Medicare Charges at DRG | $4,175,290,309 | ||||
| Total Medicare Charges with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $20,251,024 | ||||
| Avg Charges at DRG | $34,020 | ||||
| Avg Charges with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $34,324 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | NA | ||||
| SNF Discharge Rate at DRG | 21.64 | ||||
| SNF Discharge Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 10.85 | ||||
| Home Discharge Rate at DRG | 28.06 | ||||
| Home Discharge Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 15.25 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 073: CRANIAL AND PERIPHERAL NERVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 945: REHABILITATION WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 120,351 | ||||
| Total Hospitalizations with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 218 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter in DRG | 3.02 | ||||
| Avg LOS at DRG | 12.45 | ||||
| Avg LOS with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 11.73 | ||||
| Readmission Rate at DRG | 17.61 | ||||
| Readmission Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 25.56 | ||||
| Unplanned Readmission Rate at DRG | 12.6 | ||||
| Unplanned Readmission Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 16.67 | ||||
| Total Medicare payments at DRG | $2,245,410,425 | ||||
| Total Medicare payments with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $3,909,377 | ||||
| Total Medicare payment per Day at DRG | $1,499 | ||||
| Total Medicare payment per Day with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $1,528 | ||||
| Total Medicare payment per Hospitalization at DRG | $18,657 | ||||
| Total Medicare payment per Hospitalization with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $17,933 | ||||
| Total Medicare Charges at DRG | $5,810,478,166 | ||||
| Total Medicare Charges with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $10,342,601 | ||||
| Avg Charges at DRG | $48,279 | ||||
| Avg Charges with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $47,443 | ||||
| Mortality Rate at DRG | 0.55 | ||||
| Mortality Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | NA | ||||
| SNF Discharge Rate at DRG | 14.77 | ||||
| SNF Discharge Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 7.34 | ||||
| Home Discharge Rate at DRG | 22.27 | ||||
| Home Discharge Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 20.64 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 160,950 | ||||
| Total Hospitalizations with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 126 | ||||
| DRG Share of Total Hospitalizations | 0.49 | ||||
| % of Total ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter in DRG | 1.75 | ||||
| Avg LOS at DRG | 4.98 | ||||
| Avg LOS with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 9.11 | ||||
| Readmission Rate at DRG | 20.85 | ||||
| Readmission Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 27.68 | ||||
| Unplanned Readmission Rate at DRG | 13.4 | ||||
| Unplanned Readmission Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 19.64 | ||||
| Total Medicare payments at DRG | $1,184,949,733 | ||||
| Total Medicare payments with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $1,795,318 | ||||
| Total Medicare payment per Day at DRG | $1,477 | ||||
| Total Medicare payment per Day with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $1,564 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,362 | ||||
| Total Medicare payment per Hospitalization with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $14,249 | ||||
| Total Medicare Charges at DRG | $4,222,078,897 | ||||
| Total Medicare Charges with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $4,434,136 | ||||
| Avg Charges at DRG | $26,232 | ||||
| Avg Charges with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $35,192 | ||||
| Mortality Rate at DRG | 0.67 | ||||
| Mortality Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | NA | ||||
| SNF Discharge Rate at DRG | 22.29 | ||||
| SNF Discharge Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 11.11 | ||||
| Home Discharge Rate at DRG | 35.46 | ||||
| Home Discharge Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 27.78 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 417,755 | ||||
| Total Hospitalizations with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 78 | ||||
| DRG Share of Total Hospitalizations | 1.27 | ||||
| % of Total ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter in DRG | 1.08 | ||||
| Avg LOS at DRG | 3.9 | ||||
| Avg LOS with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 5.72 | ||||
| Readmission Rate at DRG | 16.53 | ||||
| Readmission Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 27.03 | ||||
| Unplanned Readmission Rate at DRG | 11.52 | ||||
| Unplanned Readmission Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | NA | ||||
| Total Medicare payments at DRG | $2,493,587,688 | ||||
| Total Medicare payments with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $840,460 | ||||
| Total Medicare payment per Day at DRG | $1,529 | ||||
| Total Medicare payment per Day with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $1,884 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,969 | ||||
| Total Medicare payment per Hospitalization with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $10,775 | ||||
| Total Medicare Charges at DRG | $11,318,800,289 | ||||
| Total Medicare Charges with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $2,509,992 | ||||
| Avg Charges at DRG | $27,094 | ||||
| Avg Charges with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | $32,179 | ||||
| Mortality Rate at DRG | 0.87 | ||||
| Mortality Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | NA | ||||
| SNF Discharge Rate at DRG | 17.03 | ||||
| SNF Discharge Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | NA | ||||
| Home Discharge Rate at DRG | 53.31 | ||||
| Home Discharge Rate with ICD T451X5D - Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | 62.82 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 210 |
| STANFORD HEALTHCARE | 300 PASTEUR DR | STANFORD | CA | 94305 | 86 |
| COMMUNITY HOSPITAL | 901 MACARTHUR BLVD | MUNSTER | IN | 46321 | 80 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. KARYN RAE DODDY | 1701 BEARDEN DR | LAS VEGAS | NV | 89106 | 27 |
| Dr. MOHAMMED A CHOWDHURY | 909 E PALATINE RD | PALATINE | IL | 60074 | 18 |
| Dr. FARZIN FARHANG | 2036 GLENVIEW DR | LAS VEGAS | NV | 89134 | 15 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. PADMAJA KONDAMURI | 8840 CALUMET AVE | MUNSTER | IN | 46321 | 71 |
| Dr. PATRICK WILLIAM DONOVAN | 1011 COLLIER ST | FORT WORTH | TX | 76102 | 45 |
| Dr. JIMMY WAYNE LOCKHART | 1600 37TH STREET | VERO BEACH | FL | 32960 | 41 |